Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2017 056 024.3 |
96 | EP file number | EAKZ | 17 82 9499.7 |
86 | WO file number | WAKZ | PCT/US2017/067470 |
97 | EP publication number | EPN | 3559011 |
87 | WO publication number | WPN | 2018119013 |
54 | Designation/title | TI | ANTIVIRALE ALIPHATISCHE ESTER-PRODRUGS VON TENOFOVIR |
51 | IPC main class | ICM (ICMV) | C07F 9/6561 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/675 (2006.01), A61P 31/18 (2006.01) |
22 | DE application date | DAT | Dec 20, 2017 |
96 | EP application date | EAT | Dec 20, 2017 |
86 | WO application date | WAT | Dec 20, 2017 |
43 | Date of first publication | OT | Jun 28, 2018 |
| Date of publication of grant | PET | Apr 13, 2022 |
71/73 | Applicant/owner | INH | Idenix Pharmaceuticals LLC, Cambridge, MA, US; Merck Sharp & Dohme LLC, Rahway, NJ, US |
72 | Inventor | IN | RAHEEM, Izzat, West Point, Pennsylvania 19486, US; PAPARIN, Jean-Laurent, 34230 Vendemian, FR; RAHALI, Houcine, 30126 Saint Laurent des Arbres, FR; DA COSTA, Daniel, 34570 Montarnaud, FR; DUKHAN, David, 34000 Montpellier, FR |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201662437753 P Dec 22, 2016
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762574493 P Oct 19, 2017
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003559011A1 Searchable text:
EP000003559011A1 Original document:
EP000003559011B1 Searchable text:
EP000003559011B1 Original document:
WO002018119013 Searchable text:
WO002018119013 |
43 | Date of first publication | EVT | Jun 28, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Oct 30, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 27, 2024 (Show all update days)(Hide all update days)- Nov 27, 2024
- St.36: changed (technical change)
- Nov 16, 2024
- Oct 10, 2024
- St.36: changed (technical change)
- Jul 20, 2024
- St.36: changed (technical change)
- Jun 13, 2024; May 2, 2024; Apr 11, 2024; Nov 15, 2023; Mar 30, 2023; Mar 2, 2023; Nov 3, 2022; Sep 30, 2022; Jun 28, 2022; Apr 23, 2022; Mar 29, 2022; Mar 24, 2022
- Historical data not available for this/these date(s)
- Oct 30, 2019
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 29, 2022 |
| Issue number | HN | 45 |
| Year | PJ | 2022 |
| Publication date | VT | Nov 10, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Idenix Pharmaceuticals LLC, Cambridge, MA, US; Merck Sharp & Dohme LLC, Rahway, NJ, US |
71/73 | Previous applicant/owner | INHF | Idenix Pharmaceuticals LLC, Cambridge, MA, US, Merck Sharp & Dohme Corp., Rahway, NJ, US |
| Date of update of the procedure | REGT | Nov 3, 2022 |